1. Jackson, A. H., Sancovich, H. A., Ferramola, A. M., Evans, N., Games, D. E., Matlin, S. A., et al. (1976). Macrocyclic intermediates in the biosynthesis of porphyrins. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences, 273, 191–206.
2. Anderson, K. E., Sassa, S., Bishop, D. F., & Desnick, R. J. (2001). Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In C. S. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular bases of inherited disease (8th ed., Vol. 2, pp. 2991–3062). New York: McGraw-Hill.
3. Kappas, A., Sassa, S., Galbraith, R. A., & Nordmann, Y. (1995). The Porphyrias. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The metabolic and molecular basis of inherited disease (7th ed., pp. 2103–2159). New York: McGraw-Hill.
4. Elder, G. H. (1988). Porphyria cutanea tarda. Seminars in Liver Disease, 18, 67–75.
5. Thusberg, J., & Vihinen, M. (2009). Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methods. Human Mutation, 30, 703–714.